Global Immune Health Supplements Market – Industry Trends and Forecast to 2029

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Free Sample Report Free Sample Report Inquire Before Buying Inquire Before Buy Now Buy Now

Global Immune Health Supplements Market – Industry Trends and Forecast to 2029

  • Food & Beverage
  • Sep 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60
  • Author : Pawan Gusain

Circumvent the Tariff challenges with an agile supply chain Consulting

Supply Chain Ecosystem Analysis now part of DBMR Reports

Global Immune Health Supplements Market, By Ingredients (Vitamins, Minerals, Herbal and Botanical Extracts, Omega 3 Fatty Acids, Amino Acids, Probiotics and Others), Form (Capsule, Tablets, Powder and Liquid), Source (Plant based and Animal Based), Distribution Channel (Supermarkets and Hypermarkets, Drug Stores, Specialty Stores, Online and Others) – Industry Trends and Forecast to 2029.

Immune Health Supplements Market

Immune Health Supplements Market Analysis and Size

As consumers become more concerned about their health, immunity care has become an essential part of today's hectic lifestyle. Nutritional supplements are used by today's time-saving consumers, including those who follow healthy, balanced diets. Consumers all over the world are feeling the need to strengthen their immune systems in order to avoid the negative consequences of infectious diseases.

Data Bridge Market Research analyses that the immune health supplements market which was growing at a value of 62.21 billion in 2021 and is expected to reach the value of USD 159.62 billion by 2029, at a CAGR of 12.50% during the forecast period of 2022-2029. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include in-depth expert analysis, geographically represented company-wise production and capacity, network layouts of distributors and partners, detailed and updated price trend analysis and deficit analysis of supply chain and demand.

Immune Health Supplements Market Scope and Segmentation

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2014 - 2019)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Ingredients (Vitamins, Minerals, Herbal and Botanical Extracts, Omega 3 Fatty Acids, Amino Acids, Probiotics and Others), Form (Capsule, Tablets, Powder and Liquid), Source (Plant based and Animal Based), Distribution Channel (Supermarkets and Hypermarkets, Drug Stores, Specialty Stores, Online and Others),

Countries Covered

U.S., Canada and Mexico in North America, Germany, Sweden, Poland, Denmark, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

Bayer AG (Germany), Pfizer Inc. (U.S.), Sun Pharmaceutical Industries Limited (India), Swisse Wellness Pty Ltd. (Australia), GSK PLC (U.K.), Abbott (U.S.), Amway Corp. (U.S.), Nature's Bounty (U.S.), Herbalife International Inc. (U.S.), Himalaya Food International Ltd. (India), American Health (U.S.), Unilever (U.K.), Sanofi (France), Novartis AG (Switzerland), Boehringer Ingelheim International GmbH (Germany), Nestle S.A. (Switzerland), Danone SA (France)

Opportunities

  • Positive impact of vital Immune health supplements is inundating the cosmetics and personal care industry
  • Recent coronavirus outbreak
  • The trend toward individualised nutrition is significant

Market Definition

Immune health supplements are well-known for their importance in managing chronic conditions such as indigestion, malabsorption, constipation, diabetes, and obesity. Regular consumption of these supplements aids in maintaining a healthy lifestyle, reduces the risk of nutrient deficiencies, promotes a healthy appetite, and protects the body from various health conditions. These supplements are available for all age groups, including geriatrics, adults, children, and infants, and benefit those who are predisposed to conditions like obesity and diabetes, chronic and neurological diseases, or renal failures, among others.

Global Immune Health Supplements Market Dynamics

Drivers

  • Growing need to boost immunity in these crucial times is augmenting market growth

Immune health supplements have a significant impact on boosting the body's immune system and aiding in the prevention of infectious diseases. Several studies have found a link between diabetes and the occurrence of chronic diseases. It also raises the likelihood of infectious disease. As a result, there is a growing interest among diabetic patients in the consumption of supplements to improve their immune system, which can provide significant value in combating infectious diseases.

  • Manufacturers are focusing on key market trends about consumer needs and demands

Food and beverage manufacturers are focusing on key market trends about consumer needs, to develop innovative products and increase sales across their entire product line. As a result, in recent years, several companies have launched innovative Immune health supplements products that provide consumers with healthy options. Thus, the growing preference for plant-based foods and the increasing use of immune health supplements in a variety of products are expected to drive the immune health supplements market over the forecast period.

Furthermore, the high prevalence of lifestyle disorders such as diabetes, obesity, and others, as well as the growing global elderly population, have increased demand for dietary supplements to assist people in managing their health risks.

Opportunity

Furthermore, the trend toward individualised nutrition is significant, especially among people with minor metabolic abnormalities or gut-related health conditions that typically fall outside the scope of generic treatment. Another significant factor driving demand for immune health supplements is the recent coronavirus outbreak, which highlighted the importance of a healthy immune system in preventing infection.

Restraints

Lack of consumer awareness about immune health supplements will act as a restraint and further challenge the growth of the immune health supplements market during the forecast period.

This immune health supplements market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the immune health supplements market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Immune Health Supplements Market

The eruption of Covid-19 positively impacted the growth of the immune health supplement market. The pandemic has significantly impacted regions such as Asia Pacific, Europe, and North America. France, India, the United States, Russia, and the United Kingdom had the highest number of Covid-19 cases. The large population in these regions, combined with the growing acceptance of supplements to boost the body's immune structure, is expected to propel the market during the forecast period.

Recent Development

  • In July 2019: Simply Probiotic by Immune Healthife Nutrition, a patented, shelf-stable probiotic strain based on GanedenBC30 formulation, was launched. This preparation will aid in the survival of a gastric passage in the intestines.
  • In November 2021: Swanson Health Products introduced 14 new probiotic supplement variants to provide customised benefits for older adults, women, and children. It will benefit colon health, immunity, digestion, and flora support.
  • In July 2019, a new consumer healthcare joint venture was formed by combining GSK and Pfizer Inc.'s healthcare businesses to operate globally under the name GSK Consumer Healthcare.

Global Immune Health Supplements Market Scope

The immune health supplements market is segmented on the basis of ingredients, form, source and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Ingredients

  • Vitamins
  • Minerals
  • Herbal and Botanical Extracts
  • Omega 3 Fatty Acids
  • Amino Acids
  • Probiotics
  • Others

Form  

  • Capsule
  • Tablets
  • Powder
  • Liquid

Source

  • Plant based
  • Animal based

Distribution channel

  • Supermarkets and Hypermarkets
  • Drug Stores
  • Specialty Stores
  • Online and Others

Immune Health Supplements Market Regional Analysis/Insights

The immune health supplements market is analysed and market size insights and trends are provided by country, ingredients, form, source and distribution channel as referenced above.

The countries covered in the immune health supplements market report are U.S., Canada and Mexico in North America, Germany, Sweden, Poland, Denmark, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominated the global immune health supplements market in terms of revenue. The rising awareness among people, as well as the highest customer source for immune health supplements, are expected to stimulate the expansion of the local market during the forecast period. Furthermore, the growing proclivity of US residents to invest in preventative supplements is expected to drive market expansion in this region.

The country section of the report also provides individual market impacting factors and changes in market regulation that impact the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Immune Health Supplements Market Share Analysis

The immune health supplements market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to Immune health supplements market.

Some of the major players operating in the immune health supplements market are:

  • Bayer AG (Germany)
  • Pfizer Inc. (U.S.)
  • Sun Pharmaceutical Industries Limited (India)
  • Swisse Wellness Pty Ltd. (Australia)
  • GSK PLC (U.K.)
  • Abbott (U.S.)
  • Amway Corp. (U.S.)
  • Nature's Bounty (U.S.)
  • Herbalife International Inc. (U.S.)
  • Himalaya Food International Ltd. (India)
  • American Health (U.S.)
  • Unilever (U.K.)
  • Sanofi (France)
  • Novartis AG (Switzerland)
  • Boehringer Ingelheim International GmbH (Germany)
  • Nestle S.A. (Switzerland)
  • Danone SA (France)


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

Table of Content

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF GLOBAL IMMUNE HEALTH SUPPLEMENTS MARKET

1.4 CURRENCY AND PRICING

1.5 LIMITATION

1.6 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 KEY TAKEAWAYS

2.2 ARRIVING AT THE GLOBAL IMMUNE HEALTH SUPPLEMENTS MARKET SIZE

2.2.1 VENDOR POSITIONING GRID

2.2.2 TECHNOLOGY LIFE LINE CURVE

2.2.3 TRIPOD DATA VALIDATION MODEL

2.2.4 MARKET GUIDE

2.2.5 MULTIVARIATE MODELLING

2.2.6 TOP TO BOTTOM ANALYSIS

2.2.7 CHALLENGE MATRIX

2.2.8 APPLICATION COVERAGE GRID

2.2.9 STANDARDS OF MEASUREMENT

2.2.10 VENDOR SHARE ANALYSIS

2.2.11 SALES VOLUME DATA

2.2.12 DATA POINTS FROM KEY PRIMARY INTERVIEWS

2.2.13 DATA POINTS FROM KEY SECONDARY DATABASES

2.3 GLOBAL IMMUNE HEALTH SUPPLEMENTS MARKET : RESEARCH SNAPSHOT

2.4 ASSUMPTIONS

3 MARKET OVERVIEW

3.1 DRIVERS

3.2 RESTRAINTS

3.3 OPPORTUNITIES

3.4 CHALLENGES

4 EXECUTIVE SUMMARY

5 PREMIUM INSIGHTS

5.1 PESTEL ANALYSIS

5.2 PORTER’S FIVE FORCES MODEL

6 INDUSTRY INSIGHTS

6.1 MICRO AND MACRO ECONOMIC FACTORS

6.2 PENETRATION AND GROWTH PROSPECT MAPPING

6.3 KEY PRICING STRATEGIES

6.4 INTERVIEWS WITH SPECIALIST

6.5 ANALYIS AND RECOMMENDATION

7 INTELLECTUAL PROPERTY (IP) PORTFOLIO

7.1 PATENT QUALITY AND STRENGTH

7.2 PATENT FAMILIES

7.3 LICENSING AND COLLABORATIONS

7.4 COMPETITIVE LANDSCAPE

7.5 IP STRATEGY AND MANAGEMENT

7.6 OTHER

8 COST ANALYSIS BREAKDOWN

9 TECHNONLOGY ROADMAP

10 INNOVATION TRACKER AND STRATEGIC ANALYSIS

10.1 MAJOR DEALS AND STRATEGIC ALLIANCES ANALYSIS

10.1.1 JOINT VENTURES

10.1.2 MERGERS AND ACQUISITIONS

10.1.3 LICENSING AND PARTNERSHIP

10.1.4 TECHNOLOGY COLLABORATIONS

10.1.5 STRATEGIC DIVESTMENTS

10.2 NUMBER OF PRODUCTS IN DEVELOPMENT

10.3 STAGE OF DEVELOPMENT

10.4 TIMELINES AND MILESTONES

10.5 INNOVATION STRATEGIES AND METHODOLOGIES

10.6 RISK ASSESSMENT AND MITIGATION

10.7 MERGERS AND ACQUISITIONS

10.8 FUTURE OUTLOOK

11 REGULATORY COMPLIANCE

11.1 REGULATORY AUTHORITIES

11.2 REGULATORY CLASSIFICATIONS

11.3 REGULATORY SUBMISSIONS

11.4 INTERNATIONAL HARMONIZATION

11.5 COMPLIANCE AND QUALITY MANAGEMENT SYSTEMS

11.6 REGULATORY CHALLENGES AND STRATEGIES

FIGURE 1 TOP ENTITIES BASED ON R&D GLANCE FOR GLOBAL IMMUNE HEALTH SUPPLEMENTS MARKET

 

Sources: Press Releases, Annual Reports, SEC Filings, Investor Presentations, Other Government Sources, Analysis Based on Inputs from Secondary, Expert Interviews

12 REIMBURSEMENT FRAMEWORK

13 OPPUTUNITY MAP ANALYSIS

14 VALUE CHAIN ANALYSIS

15 HEALTHCARE ECONOMY

15.1 HEALTHCARE EXPENDITURE

15.2 CAPITAL EXPENDITURE

15.3 CAPEX TRENDS

15.4 CAPEX ALLOCATION

15.5 FUNDING SOURCES

15.6 INDUSTRY BENCHMARKS

15.7 GDP RATION IN OVERALL GDP

15.8 HEALTHCARE SYSTEM STRUCTURE

15.9 GOVERNMENT POLICIES

15.1 ECONOMIC DEVELOPMENT

16 GLOBAL IMMUNE HEALTH SUPPLEMENTS MARKET, BY INGREDIENTS

16.1 OVERVIEW

16.2 VITAMINS

16.2.1 VITAMIN C

16.2.2 VITAMIN D

16.2.3 OTHERS

16.3 MINERALS

16.4 HERBAL AND BOTANICAL EXTRACTS

16.5 OMEGA 3 FATTY ACIDS

16.6 AMINO ACIDS

16.7 PROBIOTICS

16.8 OTHERS

17 GLOBAL IMMUNE HEALTH SUPPLEMENTS MARKET, BY FORM

17.1 OVERVIEW

17.2 CAPSULE

17.3 TABLETS

17.4 POWDER

17.5 LIQUID

18 GLOBAL IMMUNE HEALTH SUPPLEMENTS MARKET, BY SOURCE

18.1 OVERVIEW

18.2 PLANT-BASED

18.3 ANIMAL-BASED

19 GLOBAL IMMUNE HEALTH SUPPLEMENTS MARKET, BY AGE

19.1 OVERVIEW

19.2 UP TO 30

19.3 31 TO 50

19.4 MORE THAN 50

20 GLOBAL IMMUNE HEALTH SUPPLEMENTS MARKET, BY GENDER

20.1 OVERVIEW

20.2 MEN

20.3 WOMEN

21 GLOBAL IMMUNE HEALTH SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL

21.1 OVERVIEW

21.2 ONLINE

21.2.1 ONLINE

21.2.1.1. OWN WEBSITE

21.2.1.2. 3RD PARTY WEBSITE

21.3 OFFLINE

21.3.1 OFFLINE

21.3.1.1. SPECIALTY STORES

21.3.1.2. SUPERMARKETS AND HYPERMARKETS

21.3.1.3. DRUG STORES

21.3.1.4. OTHERS

22 GLOBAL IMMUNE HEALTH SUPPLEMENTS MARKET, BY GEOGRAPHY

GLOBAL IMMUNE HEALTH SUPPLEMENTS MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)

22.1 NORTH AMERICA

22.1.1 U.S.

22.1.2 CANADA

22.1.3 MEXICO

22.2 EUROPE

22.2.1 GERMANY

22.2.2 FRANCE

22.2.3 U.K.

22.2.4 HUNGARY

22.2.5 LITHUANIA

22.2.6 AUSTRIA

22.2.7 IRELAND

22.2.8 NORWAY

22.2.9 POLAND

22.2.10 ITALY

22.2.11 SPAIN

22.2.12 RUSSIA

22.2.13 TURKEY

22.2.14 NETHERLANDS

22.2.15 SWITZERLAND

22.2.16 REST OF EUROPE

22.3 ASIA-PACIFIC

22.3.1 JAPAN

22.3.2 CHINA

22.3.3 TAIWAN

22.3.4 SOUTH KOREA

22.3.5 INDIA

22.3.6 AUSTRALIA

22.3.7 SINGAPORE

22.3.8 THAILAND

22.3.9 MALAYSIA

22.3.10 INDONESIA

22.3.11 PHILIPPINES

22.3.12 VIETNAM

22.3.13 REST OF ASIA-PACIFIC

22.4 SOUTH AMERICA

22.4.1 BRAZIL

22.4.2 ECUADOR

22.4.3 CHILE

22.4.4 COLOMBIA

22.4.5 VENEZUELA

22.4.6 ARGENTINA

22.4.7 PERU

22.4.8 REST OF SOUTH AMERICA

22.5 MIDDLE EAST AND AFRICA

22.5.1 SOUTH AFRICA

22.5.2 SAUDI ARABIA

22.5.3 UAE

22.5.4 EGYPT

22.5.5 KUWAIT

22.5.6 ISRAEL

22.5.7 REST OF MIDDLE EAST AND AFRICA

22.6 KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES

23 GLOBAL IMMUNE HEALTH SUPPLEMENTS MARKET, COMPANY LANDSCAPE

23.1 COMPANY SHARE ANALYSIS: GLOBAL

23.2 COMPANY SHARE ANALYSIS: NORTH AMERICA

23.3 COMPANY SHARE ANALYSIS: EUROPE

23.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC

23.5 MERGERS & ACQUISITIONS

23.6 NEW PRODUCT DEVELOPMENT & APPROVALS

23.7 EXPANSIONS

23.8 REGULATORY CHANGES

23.9 PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS

24 GLOBAL IMMUNE HEALTH SUPPLEMENTS MARKET, SWOT AND DBMR ANALYSIS

25 GLOBAL IMMUNE HEALTH SUPPLEMENTS MARKET, COMPANY PROFILE

25.1 BIO-RAD LABORATORIES, INC.

25.1.1 COMPANY OVERVIEW

25.1.2 REVENUE ANALYSIS

25.1.3 GEOGRAPHIC PRESENCE

25.1.4 PRODUCT PORTFOLIO

25.1.5 RECENT DEVELOPMENTS

25.2 ABBOTT

25.2.1 COMPANY OVERVIEW

25.2.2 REVENUE ANALYSIS

25.2.3 GEOGRAPHIC PRESENCE

25.2.4 PRODUCT PORTFOLIO

25.2.5 RECENT DEVELOPMENTS

25.3 SIEMENS HEALTHINEERS AG

25.3.1 COMPANY OVERVIEW

25.3.2 REVENUE ANALYSIS

25.3.3 GEOGRAPHIC PRESENCE

25.3.4 PRODUCT PORTFOLIO

25.3.5 RECENT DEVELOPMENTS

25.4 DANAHER

25.4.1 COMPANY OVERVIEW

25.4.2 REVENUE ANALYSIS

25.4.3 GEOGRAPHIC PRESENCE

25.4.4 PRODUCT PORTFOLIO

25.4.5 RECENT DEVELOPMENTS

25.5 DIASORIN S.P.A.

25.5.1 COMPANY OVERVIEW

25.5.2 REVENUE ANALYSIS

25.5.3 GEOGRAPHIC PRESENCE

25.5.4 PRODUCT PORTFOLIO

25.5.5 RECENT DEVELOPMENTS

25.6 ALPCO

25.6.1 COMPANY OVERVIEW

25.6.2 REVENUE ANALYSIS

25.6.3 GEOGRAPHIC PRESENCE

25.6.4 PRODUCT PORTFOLIO

25.6.5 RECENT DEVELOPMENTS

25.7 BIOASSAY SYSTEMS

25.7.1 COMPANY OVERVIEW

25.7.2 REVENUE ANALYSIS

25.7.3 GEOGRAPHIC PRESENCE

25.7.4 PRODUCT PORTFOLIO

25.7.5 RECENT DEVELOPMENTS

25.8 DIAGNOSTIC AUTOMATION/CORTEZ DIAGNOSTICS INC.

25.8.1 COMPANY OVERVIEW

25.8.2 REVENUE ANALYSIS

25.8.3 GEOGRAPHIC PRESENCE

25.8.4 PRODUCT PORTFOLIO

25.8.5 RECENT DEVELOPMENTS

25.9 DIAZYME LABORATORIES, INC

25.9.1 COMPANY OVERVIEW

25.9.2 REVENUE ANALYSIS

25.9.3 GEOGRAPHIC PRESENCE

25.9.4 PRODUCT PORTFOLIO

25.9.5 RECENT DEVELOPMENTS

25.1 ABNOVA CORPORATION

25.10.1 COMPANY OVERVIEW

25.10.2 REVENUE ANALYSIS

25.10.3 GEOGRAPHIC PRESENCE

25.10.4 PRODUCT PORTFOLIO

25.10.5 RECENT DEVELOPMENTS

25.11 DRG INSTRUMENTS GMBH

25.11.1 COMPANY OVERVIEW

25.11.2 REVENUE ANALYSIS

25.11.3 GEOGRAPHIC PRESENCE

25.11.4 PRODUCT PORTFOLIO

25.11.5 RECENT DEVELOPMENTS

25.12 EKF DIAGNOSTICS HOLDINGS PLC

25.12.1 COMPANY OVERVIEW

25.12.2 REVENUE ANALYSIS

25.12.3 GEOGRAPHIC PRESENCE

25.12.4 PRODUCT PORTFOLIO

25.12.5 RECENT DEVELOPMENTS

25.13 ETHOS BIOSCIENCES, INC.

25.13.1 COMPANY OVERVIEW

25.13.2 REVENUE ANALYSIS

25.13.3 GEOGRAPHIC PRESENCE

25.13.4 PRODUCT PORTFOLIO

25.13.5 RECENT DEVELOPMENTS

25.14 MEDIPAN GMBH

25.14.1 COMPANY OVERVIEW

25.14.2 REVENUE ANALYSIS

25.14.3 GEOGRAPHIC PRESENCE

25.14.4 PRODUCT PORTFOLIO

25.14.5 RECENT DEVELOPMENTS

25.15 MERCK KGAA

25.15.1 COMPANY OVERVIEW

25.15.2 REVENUE ANALYSIS

25.15.3 GEOGRAPHIC PRESENCE

25.15.4 PRODUCT PORTFOLIO

25.15.5 RECENT DEVELOPMENTS

25.16 MONOBIND INC.

25.16.1 COMPANY OVERVIEW

25.16.2 REVENUE ANALYSIS

25.16.3 GEOGRAPHIC PRESENCE

25.16.4 PRODUCT PORTFOLIO

25.16.5 RECENT DEVELOPMENTS

25.17 ORGENTEC DIAGNOSTIKA GMBH

25.17.1 COMPANY OVERVIEW

25.17.2 REVENUE ANALYSIS

25.17.3 GEOGRAPHIC PRESENCE

25.17.4 PRODUCT PORTFOLIO

25.17.5 RECENT DEVELOPMENTS

25.18 ORTHO CLINICAL DIAGNOSTICS

25.18.1 COMPANY OVERVIEW

25.18.2 REVENUE ANALYSIS

25.18.3 GEOGRAPHIC PRESENCE

25.18.4 PRODUCT PORTFOLIO

25.18.5 RECENT DEVELOPMENTS

25.19 PTS DIAGNOSTICS (A SUBSIDIARY OF SANNUO BIOSENSOR CO., LTD.)

25.19.1 COMPANY OVERVIEW

25.19.2 REVENUE ANALYSIS

25.19.3 GEOGRAPHIC PRESENCE

25.19.4 PRODUCT PORTFOLIO

25.19.5 RECENT DEVELOPMENTS

25.2 TOSOH CORPORATION

25.20.1 COMPANY OVERVIEW

25.20.2 REVENUE ANALYSIS

25.20.3 GEOGRAPHIC PRESENCE

25.20.4 PRODUCT PORTFOLIO

25.20.5 RECENT DEVELOPMENTS

25.21 F. HOFFMANN-LA ROCHE AG

25.21.1 COMPANY OVERVIEW

25.21.2 REVENUE ANALYSIS

25.21.3 GEOGRAPHIC PRESENCE

25.21.4 PRODUCT PORTFOLIO

25.21.5 RECENT DEVELOPMENTS

25.22 NOVO NORDISK A/S

25.22.1 COMPANY OVERVIEW

25.22.2 REVENUE ANALYSIS

25.22.3 GEOGRAPHIC PRESENCE

25.22.4 PRODUCT PORTFOLIO

25.22.5 RECENT DEVELOPMENTS

25.23 ARKRAY INC

25.23.1 COMPANY OVERVIEW

25.23.2 REVENUE ANALYSIS

25.23.3 GEOGRAPHIC PRESENCE

25.23.4 PRODUCT PORTFOLIO

25.23.5 RECENT DEVELOPMENTS

25.24 ASCENSIA DIABETES CARE

25.24.1 COMPANY OVERVIEW

25.24.2 REVENUE ANALYSIS

25.24.3 GEOGRAPHIC PRESENCE

25.24.4 PRODUCT PORTFOLIO

25.24.5 RECENT DEVELOPMENTS

25.25 LIFESCAN IP HOLDING, LLC

25.25.1 COMPANY OVERVIEW

25.25.2 REVENUE ANALYSIS

25.25.3 GEOGRAPHIC PRESENCE

25.25.4 PRODUCT PORTFOLIO

25.25.5 RECENT DEVELOPMENTS

25.26 DEXCOM, INC.

25.26.1 COMPANY OVERVIEW

25.26.2 REVENUE ANALYSIS

25.26.3 GEOGRAPHIC PRESENCE

25.26.4 PRODUCT PORTFOLIO

25.26.5 RECENT DEVELOPMENTS

25.27 MEDTRONIC

25.27.1 COMPANY OVERVIEW

25.27.2 REVENUE ANALYSIS

25.27.3 GEOGRAPHIC PRESENCE

25.27.4 PRODUCT PORTFOLIO

25.27.5 RECENT DEVELOPMENTS

25.28 B. BRAUN MELSUNGEN AG

25.28.1 COMPANY OVERVIEW

25.28.2 REVENUE ANALYSIS

25.28.3 GEOGRAPHIC PRESENCE

25.28.4 PRODUCT PORTFOLIO

25.28.5 RECENT DEVELOPMENTS

25.29 TERUMO CORPORATION

25.29.1 COMPANY OVERVIEW

25.29.2 REVENUE ANALYSIS

25.29.3 GEOGRAPHIC PRESENCE

25.29.4 PRODUCT PORTFOLIO

25.29.5 RECENT DEVELOPMENTS

25.3 ACON LABORATORIES, INC.

25.30.1 COMPANY OVERVIEW

25.30.2 REVENUE ANALYSIS

25.30.3 GEOGRAPHIC PRESENCE

25.30.4 PRODUCT PORTFOLIO

25.30.5 RECENT DEVELOPMENTS

26 CONCLUSION

27 QUESTIONNAIRE

28 ABOUT DATA BRIDGE MARKET RESEARCH

View Detailed Information Right Arrow

Global Immune Health Supplements Market, Supply Chain Analysis and Ecosystem Framework

To support market growth and help clients navigate the impact of geopolitical shifts, DBMR has integrated in-depth supply chain analysis into its Global Immune Health Supplements Market research reports. This addition empowers clients to respond effectively to global changes affecting their industries. The supply chain analysis section includes detailed insights such as Global Immune Health Supplements Market consumption and production by country, price trend analysis, the impact of tariffs and geopolitical developments, and import and export trends by country and HSN code. It also highlights major suppliers with data on production capacity and company profiles, as well as key importers and exporters. In addition to research, DBMR offers specialized supply chain consulting services backed by over a decade of experience, providing solutions like supplier discovery, supplier risk assessment, price trend analysis, impact evaluation of inflation and trade route changes, and comprehensive market trend analysis.

Research Methodology

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Customization Available

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The Immune Health Supplements Market value is projected USD 159.62 billion by 2029.
The market is expected to grow at a rate of market is 12.50% during the forecast period of 2022 to 2029.
The major players operating in the Immune Health Supplements Market are Bayer AG (Germany), Pfizer Inc. (U.S.), Sun Pharmaceutical Industries Limited (India), Swisse Wellness Pty Ltd. (Australia), GSK PLC (U.K.), Abbott (U.S.), Amway Corp. (U.S.), Nature's Bounty (U.S.), Herbalife International Inc. (U.S.), Himalaya Food International Ltd. (India), American Health (U.S.), Unilever (U.K.), Sanofi (France), Novartis AG (Switzerland), Boehringer Ingelheim International GmbH (Germany), Nestle S.A. (Switzerland), Danone SA (France).
The major countries covered in the Immune Health Supplements Market are U.S., Canada and Mexico in North America, Germany, Sweden, Poland, Denmark, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Industry Related Reports

Testimonial